Addus HomeCare Analyst Ratings
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $136
RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS)
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $141
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Raises Target Price to $141
Addus HomeCare Price Target Raised to $145.00/Share From $143.00 by Stephens & Co.
Addus HomeCare Is Maintained at Outperform by RBC Capital
Addus HomeCare Analyst Ratings
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Cuts Target Price to $136
Oppenheimer Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $145
A Quick Look at Today's Ratings for Addus HomeCare(ADUS.US), With a Forecast Between $83 to $145
Barclays Maintains Addus HomeCare(ADUS.US) With Sell Rating, Maintains Target Price $83
Addus HomeCare Analyst Ratings
Macquarie Maintains Addus HomeCare(ADUS.US) With Buy Rating
Macquarie Sticks to Their Buy Rating for Addus Homecare (ADUS)
Addus HomeCare Price Target Maintained With a $139.00/Share by Macquarie
Addus HomeCare Is Maintained at Outperform by Macquarie
Keybanc Initiates Coverage On Addus HomeCare With Overweight Rating, Announces Price Target of $150
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $137
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $137